BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  Windtree Announces Istaroxime Phase 2 Cardiogenic Shock Study Hits Enrollment Target for Planned Interim Analysis

  June 30, 2025

   · 

  5 min read
• Press Releases

  Sumitomo Pharma America and Former Professional Quarterback Rodney Peete Say it’s Time to Go™ and Put Yourself First with Overactive Bladder Treatment Option GEMTESA®

  June 30, 2025

   · 

  8 min read
• Press Releases

  FDA Grants Breakthrough Device Designation to TOBY’s AI-Powered Urine Test for Early Bladder Cancer Detection

  June 30, 2025

   · 

  2 min read
• Press Releases

  AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR BEMARITUZUMAB IN FIBROBLAST GROWTH FACTOR RECEPTOR 2b (FGFR2b) POSITIVE FIRST-LINE GASTRIC CANCER

  June 30, 2025

   · 

  11 min read
• Press Releases

  Kyverna Therapeutics Announces Appointment of New Chief Financial Officer

  June 30, 2025

   · 

  6 min read
• Press Releases

  Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer

  June 30, 2025

   · 

  8 min read
• 

  Alzheimer’s disease

  Alzheimer’s Deals Surged 780% After Leqembi, Kisunla Broke Approval Stalemate

  The rise of monoclonal antibodies brought back hope for stalling or reversing the devastating neurodegenerative disease. Big Pharma has taken notice with a handful of high-value deals, GlobalData reports.

  June 30, 2025

   · 

  2 min read

   · 

  Annalee Armstrong
• 

  Layoffs

  BMS Continues New Jersey Layoffs, Bringing Yearly Total to Nearly 900

  BMS is letting go of 68 employees in Lawrenceville, New Jersey. The pharma has now cut over 1,000 employees there since April 2024 as part of its cost-cutting measures.

  June 30, 2025

   · 

  1 min read

   · 

  Angela Gabriel
• 

  Mergers & acquisitions

  AbbVie Plunks Down $2.1B for Capstan and Its Novel CAR T Therapies

  The all-cash buyout, which gives AbbVie access to Capstan Therapeutics’ in vivo edited CAR T therapy for B cell–mediated autoimmune diseases, adds to a growing sense of momentum in M&A, according to BMO Capital Markets.

  June 30, 2025

   · 

  2 min read

   · 

  Dan Samorodnitsky
• Press Releases

  Mineralys Therapeutics Announces Journal of the American Medical Association (JAMA) Publication of Pivotal Phase 3 Launch-HTN Trial for Lorundrostat

  June 30, 2025

   · 

  9 min read